$SQZB.US$ The management has decided to defer the RS as ther...

The management has decided to defer the RS as there is no urgency now to have it.

Those bought at $0.14 now already double in return....will keep it for long term

The company has generated revenue yet to have profits which is norm for bio companies which still in process of developing a successful therapy...

Do remember Temasek Holding (Singapore arm of investing company) is biggest single share holder...